Restricted IgG Subclass Responses to HTLV-III/LAV and to Cytomegalovirus in Patients with AIDS and Lymphadenopathy Syndrome (1986)

Journal Article Restricted IgG Subclass Responses to HTLV-III/LAV and to Cytomegalovirus in Patients with AIDS and Lymphadenopathy Syndrome Get access V.-A. Sundqvist, V.-A. Sundqvist Department of Virology, National Bacteriological Laboratory, Stockholm, Sweden; the Paul Ehrlich-Institute, and the Zentrum Innere Medizin, University of Frankfurt, Frankfurt, Federal Republic of Germany; and the Laboratory for Tumor Cell Biology, National Cancer Institute, Bethesda, Maryland Search for other works by this author on: Oxford Academic PubMed Google Scholar A. Linde, A. Linde Department of Virology, National Bacteriological Laboratory, Stockholm, Sweden; the Paul Ehrlich-Institute, and the Zentrum Innere Medizin, University of Frankfurt, Frankfurt, Federal Republic of Germany; and the Laboratory for Tumor Cell Biology, National Cancer Institute, Bethesda, Maryland Search for other works by this author on: Oxford Academic PubMed Google Scholar R. Kurth, R. Kurth Department of Virology, National Bacteriological Laboratory, Stockholm, Sweden; the Paul Ehrlich-Institute, and the Zentrum Innere Medizin, University of Frankfurt, Frankfurt, Federal Republic of Germany; and the Laboratory for Tumor Cell Biology, National Cancer Institute, Bethesda, Maryland Search for other works by this author on: Oxford Academic PubMed Google Scholar A. Werner, A. Werner Department of Virology, National Bacteriological Laboratory, Stockholm, Sweden; the Paul Ehrlich-Institute, and the Zentrum Innere Medizin, University of Frankfurt, Frankfurt, Federal Republic of Germany; and the Laboratory for Tumor Cell Biology, National Cancer Institute, Bethesda, Maryland Search for other works by this author on: Oxford Academic PubMed Google Scholar E. B. Helm, E. B. Helm Department of Virology, National Bacteriological Laboratory, Stockholm, Sweden; the Paul Ehrlich-Institute, and the Zentrum Innere Medizin, University of Frankfurt, Frankfurt, Federal Republic of Germany; and the Laboratory for Tumor Cell Biology, National Cancer Institute, Bethesda, Maryland Search for other works by this author on: Oxford Academic PubMed Google Scholar M. Popovic, M. Popovic Department of Virology, National Bacteriological Laboratory, Stockholm, Sweden; the Paul Ehrlich-Institute, and the Zentrum Innere Medizin, University of Frankfurt, Frankfurt, Federal Republic of Germany; and the Laboratory for Tumor Cell Biology, National Cancer Institute, Bethesda, Maryland Search for other works by this author on: Oxford Academic PubMed Google Scholar R. C. Gallo, R. C. Gallo Department of Virology, National Bacteriological Laboratory, Stockholm, Sweden; the Paul Ehrlich-Institute, and the Zentrum Innere Medizin, University of Frankfurt, Frankfurt, Federal Republic of Germany; and the Laboratory for Tumor Cell Biology, National Cancer Institute, Bethesda, Maryland Search for other works by this author on: Oxford Academic PubMed Google Scholar B. Wahren B. Wahren Department of Virology, National Bacteriological Laboratory, Stockholm, Sweden; the Paul Ehrlich-Institute, and the Zentrum Innere Medizin, University of Frankfurt, Frankfurt, Federal Republic of Germany; and the Laboratory for Tumor Cell Biology, National Cancer Institute, Bethesda, Maryland Please address requests for reprints to Dr. Britta Wahren, Department of Virology, The National Bacteriological Laboratory, S-105 21 Stockholm, Sweden. Search for other works by this author on: Oxford Academic PubMed Google Scholar The Journal of Infectious Diseases, Volume 153, Issue 5, May 1986, Pages 970–973, https://doi.org/10.1093/infdis/153.5.970 Published: 01 May 1986 Article history Received: 03 September 1985 Revision received: 10 December 1985 Published: 01 May 1986